There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG – Research Report) and Elevance Health (ELV – Research Report) with bullish sentiments.
Intuitive Surgical (ISRG)
In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Intuitive Surgical. The company’s shares closed last Thursday at $372.63.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of
Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $421.88, implying a 13.2% upside from current levels. In a report issued on April 8, Stifel Nicolaus also maintained a Buy rating on the stock with a $430.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Elevance Health (ELV)
Truist Financial analyst David S Macdonald reiterated a Buy rating on Elevance Health today and set a price target of $600.00. The company’s shares closed last Thursday at $525.19, close to its 52-week high of $539.11.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of
Currently, the analyst consensus on Elevance Health is a Strong Buy with an average price target of $591.36, implying a 13.6% upside from current levels. In a report issued on April 8, Wells Fargo also maintained a Buy rating on the stock with a $557.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ISRG:
- Intuitive Surgical Stock (NASDAQ:ISRG) Gains after Q1 Earnings Beat
- Options Volatility and Implied Earnings Moves Today, April 18, 2024
- ISRG Upcoming Earnings Report: What to Expect?
- Intuitive Surgical added to ‘US 1 List’ at BofA, Lowe’s removed
- Intuitive Surgical price target raised to $430 from $420 at Stifel
